Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of Capecitabine in Elderly Cancer Patients
NCT00812864Phase 4Completed
- Sponsor
- CHU de Limoges
- Start
- Jan 2009
- Primary completion
- Oct 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of capecitabine in breast cancer, colorectal cancer (CRC), sponsored by CHU de Limoges. Started Jan 2009; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00812864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812864.